This study prospectively analyzed whether urine Ln‐γ2m levels as determined by chemiluminescent immunoassay offered better diagnostic accuracy than urine levels of NMP22 or BTA, or urine cytology in patients with NMIBC, patients with benign genitourinary disease (BD), and healthy donors (HD). The gene discussed is NUMA1; the disease is Behcet disease.